Concepedia

Darren Riddy

DR

12

Publications

409

Citations

11

H-Index

2006

Active since

Affiliations

Monash University(Current)

Servier (France)

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

Plateforme Technologique d'Innovation Biomédicale

Darren Riddy is an author at Monash University specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2006–2022

12

Publications

12

Investigating the molecular mechanisms through which <scp>FTY</scp>720‐<scp>P</scp> causes persistent <scp>S1P<sub>1</sub></scp> receptor internalization

David A. Sykes, Darren Riddy, Craig Stamp et al. · British Journal of Pharmacology · 2014 · 73 citations · Full text

Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy

David A. Sykes, Michelle Bradley, Darren Riddy et al. · Molecular Pharmacology · 2016 · 67 citations · Full text

Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents

Leigh C. Walker, Alice E. Berizzi, Nicola A. Chen et al. · Biological Psychiatry · 2020 · 47 citations · Full text

, , +11

Comparative genotypic and phenotypic analysis of human peripheral blood monocytes and surrogate monocyte-like cell lines commonly used in metabolic disease research

Darren Riddy, Emily Goy, Philippe Delerive et al. · PLoS ONE · 2018 · 42 citations · Full text

, , +23

Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma

David A. Sandham, Lucy Barker, Lyndon Brown et al. · ACS Medicinal Chemistry Letters · 2017 · 31 citations · Full text

Rows per page

1–5 of 12